A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Boston Children's Hospital
- Study ID
- NCT06585605
- Status
- Recruiting
Conditions
- Ataxia
- Chorea
- Dyskinesias
- Dystonia Disorder
- Epilepsy
- Epilepsy in Children
- Movement Disorders
- Movement Disorders in Children
- Myoclonus
- Neurologic Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 0 Years - 18 Years
- Healthy Volunteers
- Not accepted
Study Details
The Epilepsy-Dyskinesia Study aims to advance the understanding of the clinical and molecular spectrum of epilepsy-dyskinesia syndromes, monogenic diseases that cause both movement disorders and epilepsy. Addressing challenges in rare disease research -such as small, geographically dispersed patient populations and a lack of standardized protocols- the study employs a multinational retrospective survey endorsed by the International Parkinson and Movement Disorder Society. This survey seeks to collect comprehensive data on clinical features, disease progression, age of onset, genetic variants, and concurrent neurological conditions, standardizing data collection across countries to provide a unified understanding of these conditions. Through retrospective review and molecular data analysis, the study aims to identify patterns and correlations between movement and seizure disorders, uncovering genotype-phenotype relationships. The initiative\'s goals are to enhance understanding of epilepsy-dyskinesia syndromes, inform precision medicine approaches, and foster international collaboration.
Key Dates
- Start date
- Jul 1, 2024
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2029
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 500 participants (estimated)
Primary Outcome Measure
Creation of a Shared Clinical Database [ Time Frame: 1 year ]
Central Contacts
- Darius Ebrahimi-Fakhari, MD, PhD.617-355-0097
- Vicente Quiroz, MD
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Boston Children's Hospital | Boston | Massachusetts | 02115 | Darius Ebrahimi-Fakhari, MD, PhD (PRINCIPAL_INVESTIGATOR) Vicente Quiroz, MD (SUB_INVESTIGATOR) |
Find similar trials in Boston, MA
Related Studies
- Human Epilepsy Genetics--Neuronal Migration Disorders StudyRecruiting · Harvard University Faculty of Medicine · Boston, Massachusetts
- Genetics of Epilepsy and Related DisordersRecruiting · Boston Children's Hospital · Boston, Massachusetts
- Abbott DBS Post-Market Study of Outcomes for Indications Over TimeRecruiting · Abbott Medical Devices · Tucson, Arizona
- Methylphenidate for the Treatment of Epilepsy-related Cognitive DeficitsPHASE4 · Recruiting · VA Office of Research and Development · Miami, Florida